| Primary |
| Labour Induction |
22.3% |
| Induced Labour |
14.4% |
| Uterine Atony |
10.1% |
| Caesarean Section |
7.9% |
| Epidural Anaesthesia |
7.9% |
| Induced Abortion Haemorrhage |
5.0% |
| Local Anaesthesia |
4.3% |
| Spinal Anaesthesia |
3.6% |
| Asthma |
2.9% |
| Labour Stimulation |
2.9% |
| Premature Labour |
2.9% |
| Assisted Delivery |
2.2% |
| General Anaesthesia |
2.2% |
| Postpartum Haemorrhage |
2.2% |
| Third Stage Postpartum Haemorrhage |
2.2% |
| Anaesthesia |
1.4% |
| Analgesic Therapy |
1.4% |
| Hypertension |
1.4% |
| Labour Complication |
1.4% |
| Uterine Contractions Abnormal |
1.4% |
|
| Postpartum Haemorrhage |
31.5% |
| Uterine Atony |
14.4% |
| Drug Exposure During Pregnancy |
7.2% |
| Urticaria |
5.4% |
| Uterine Haemorrhage |
4.5% |
| Intra-uterine Death |
3.6% |
| Resuscitation |
3.6% |
| Uterine Dilation And Evacuation |
3.6% |
| Uterine Hypertonus |
3.6% |
| Cerebral Palsy |
2.7% |
| Drug Exposure Via Breast Milk |
2.7% |
| Foetal Heart Rate Deceleration |
2.7% |
| Angioedema |
1.8% |
| Drug Ineffective |
1.8% |
| Foetal Heart Rate Abnormal |
1.8% |
| Forceps Delivery |
1.8% |
| Hypotension |
1.8% |
| Life Support |
1.8% |
| Malaise |
1.8% |
| Meconium In Amniotic Fluid |
1.8% |
|
| Secondary |
| Drug Use For Unknown Indication |
26.4% |
| Caesarean Section |
10.4% |
| Postpartum Haemorrhage |
8.9% |
| Local Anaesthesia |
7.8% |
| Anaesthesia |
7.3% |
| Induced Labour |
6.3% |
| Premature Labour |
6.3% |
| Product Used For Unknown Indication |
4.4% |
| Epidural Anaesthesia |
4.2% |
| Labour Induction |
4.2% |
| Fluid Replacement |
3.1% |
| Uterine Atony |
2.3% |
| Hypertension |
2.1% |
| Delivery |
1.0% |
| Pain |
1.0% |
| Retained Placenta Or Membranes |
1.0% |
| Spinal Anaesthesia |
1.0% |
| Drug Exposure During Pregnancy |
0.8% |
| Gestational Hypertension |
0.8% |
| Amniocentesis Abnormal |
0.5% |
|
| Uterine Atony |
22.0% |
| Disseminated Intravascular Coagulation |
21.2% |
| Uterine Dilation And Evacuation |
18.6% |
| Maternal Exposure During Pregnancy |
5.9% |
| Shock |
3.4% |
| Vomiting |
3.4% |
| Postpartum Haemorrhage |
2.5% |
| Respiratory Distress |
2.5% |
| Swelling Face |
2.5% |
| Agitation |
1.7% |
| Cardiac Arrest |
1.7% |
| Obstructed Labour |
1.7% |
| Prolonged Labour |
1.7% |
| Renal Failure Acute |
1.7% |
| Renal Tubular Necrosis |
1.7% |
| Tachycardia |
1.7% |
| Thrombocytopenia |
1.7% |
| Uterine Hypertonus |
1.7% |
| Uterine Rupture |
1.7% |
| Anaphylactic Reaction |
0.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
15.4% |
| Prophylaxis |
12.4% |
| Postpartum Haemorrhage |
8.9% |
| Anaemia |
6.5% |
| Epidural Anaesthesia |
5.9% |
| Drug Use For Unknown Indication |
5.3% |
| Heart Rate Irregular |
4.7% |
| Breast Feeding |
4.1% |
| Hypersensitivity |
4.1% |
| Labour Induction |
4.1% |
| Analgesic Therapy |
3.6% |
| Drug Exposure During Pregnancy |
3.6% |
| Gastrooesophageal Reflux Disease |
3.6% |
| Anaesthesia |
3.0% |
| Haemorrhage |
3.0% |
| Chest Pain |
2.4% |
| General Anaesthesia |
2.4% |
| Pain |
2.4% |
| Spinal Anaesthesia |
2.4% |
| Thrombosis Prophylaxis |
2.4% |
|
| Premature Baby |
7.2% |
| Premature Labour |
7.2% |
| Placental Infarction |
5.8% |
| Pregnancy |
5.8% |
| Sinusitis |
5.8% |
| Splenic Infarction |
5.8% |
| Swollen Tongue |
5.8% |
| Trisomy 21 |
5.8% |
| Uterine Hypertonus |
5.8% |
| Ventricular Fibrillation |
5.8% |
| Drug Ineffective |
4.3% |
| Postpartum Haemorrhage |
4.3% |
| Speech Disorder |
4.3% |
| Thrombophlebitis Superficial |
4.3% |
| Toxicity To Various Agents |
4.3% |
| Ventricular Tachycardia |
4.3% |
| Vomiting |
4.3% |
| Cerebral Palsy |
2.9% |
| Maternal Exposure During Pregnancy |
2.9% |
| Premature Separation Of Placenta |
2.9% |
|
